Bamboos Health Care Holdings Past Earnings Performance
Past criteria checks 2/6
Bamboos Health Care Holdings has been growing earnings at an average annual rate of 1.5%, while the Healthcare industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 8.9% per year. Bamboos Health Care Holdings's return on equity is 14.2%, and it has net margins of 32.3%.
Key information
1.5%
Earnings growth rate
1.5%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | 8.9% |
| Return on equity | 14.2% |
| Net Margin | 32.3% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Be Wary Of Bamboos Health Care Holdings (HKG:2293) And Its Returns On Capital
Sep 19
Bamboos Health Care Holdings (HKG:2293) Is Reducing Its Dividend To HK$0.0375
Oct 31Bamboos Health Care Holdings (HKG:2293) Knows How To Allocate Capital
Dec 02Bamboos Health Care Holdings (HKG:2293) Is Due To Pay A Dividend Of HK$0.025
Mar 10Bamboos Health Care Holdings (HKG:2293) Has Announced A Dividend Of HK$0.025
Feb 24Shareholders May Not Be So Generous With Bamboos Health Care Holdings Limited's (HKG:2293) CEO Compensation And Here's Why
Nov 22Some Investors May Be Worried About Bamboos Health Care Holdings' (HKG:2293) Returns On Capital
Aug 20The Returns On Capital At Bamboos Health Care Holdings (HKG:2293) Don't Inspire Confidence
May 02Income Investors Should Know That Bamboos Health Care Holdings Limited (HKG:2293) Goes Ex-Dividend Soon
Mar 10Does Bamboos Health Care Holdings Limited (HKG:2293) Have A Place In Your Dividend Portfolio?
Jan 29
Here's What To Make Of Bamboos Health Care Holdings' (HKG:2293) Returns On Capital
Jan 08Bamboos Health Care Holdings Limited's (HKG:2293) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Dec 18We Think Bamboos Health Care Holdings's (HKG:2293) Statutory Profit Might Understate Its Earnings Potential
Nov 27Revenue & Expenses Breakdown
How Bamboos Health Care Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 96 | 31 | 0 | 0 |
| 31 Mar 24 | 102 | 32 | 0 | 0 |
| 31 Dec 23 | 109 | 33 | 0 | 0 |
| 30 Sep 23 | 119 | 40 | 0 | 0 |
| 30 Jun 23 | 128 | 47 | 1 | 0 |
| 31 Mar 23 | 132 | 51 | 1 | 0 |
| 31 Dec 22 | 136 | 56 | 1 | 0 |
| 30 Sep 22 | 139 | 57 | 1 | 0 |
| 30 Jun 22 | 141 | 59 | 1 | 0 |
| 31 Mar 22 | 144 | 67 | 1 | 0 |
| 31 Dec 21 | 147 | 75 | 0 | 0 |
| 30 Sep 21 | 129 | 68 | 0 | 0 |
| 30 Jun 21 | 111 | 61 | 0 | 0 |
| 31 Mar 21 | 93 | 47 | 0 | 0 |
| 31 Dec 20 | 76 | 34 | 0 | 0 |
| 30 Sep 20 | 76 | 32 | 1 | 0 |
| 30 Jun 20 | 76 | 31 | 2 | 0 |
| 31 Mar 20 | 79 | 36 | 4 | 0 |
| 31 Dec 19 | 83 | 40 | 6 | 0 |
| 30 Sep 19 | 82 | 40 | 6 | 0 |
| 30 Jun 19 | 82 | 39 | 6 | 0 |
| 31 Mar 19 | 83 | 38 | 5 | 0 |
| 31 Dec 18 | 83 | 38 | 5 | 0 |
| 30 Sep 18 | 84 | 40 | 4 | 0 |
| 30 Jun 18 | 85 | 42 | 3 | 0 |
| 31 Mar 18 | 80 | 39 | 3 | 0 |
| 31 Dec 17 | 75 | 37 | 3 | 0 |
| 30 Sep 17 | 70 | 35 | 3 | 0 |
| 30 Jun 17 | 67 | 33 | 3 | 0 |
| 31 Mar 17 | 63 | 31 | 3 | 0 |
| 31 Dec 16 | 58 | 29 | 2 | 0 |
| 30 Sep 16 | 57 | 28 | 2 | 0 |
| 30 Jun 16 | 54 | 27 | 3 | 0 |
| 31 Mar 16 | 53 | 27 | 2 | 0 |
| 31 Dec 15 | 53 | 26 | 2 | 0 |
| 30 Sep 15 | 51 | 24 | 1 | 0 |
| 30 Jun 15 | 49 | 22 | 1 | 0 |
| 31 Mar 15 | 47 | 16 | 1 | 0 |
| 31 Dec 14 | 43 | 9 | 1 | 0 |
| 30 Sep 14 | 41 | 9 | 1 | 0 |
| 30 Jun 14 | 38 | 9 | 1 | 0 |
| 31 Mar 14 | 36 | 12 | 1 | 0 |
| 31 Dec 13 | 34 | 16 | 1 | 0 |
Quality Earnings: 2293 has high quality earnings.
Growing Profit Margin: 2293's current net profit margins (32.3%) are lower than last year (36.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2293's earnings have grown by 1.5% per year over the past 5 years.
Accelerating Growth: 2293's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 2293 had negative earnings growth (-34.1%) over the past year, making it difficult to compare to the Healthcare industry average (-14.3%).
Return on Equity
High ROE: 2293's Return on Equity (14.2%) is considered low.